A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) to treat prostate cancer offers a higher cure rate than more traditional approaches, according to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center.
The study – the first trial to publish five-year results from SBRT treatment for prostate cancer – found a 98.6 percent cure rate with SBRT, a noninvasive form of radiation treatment that involves high-dose radiation beams entering the body through various angles and intersecting at the desired target. It is a state-of-the-art technology that allows for a concentrated dose to reach the tumor while limiting the radiation dose to surrounding healthy tissue.
“The high cure rate is striking when compared to the reported five-year cure rates from other approaches like surgery or conventional radiation, which range between 80 to 90 percent, while the side effects of this treatment are comparable to other types of treatment,” said Dr. Raquibul Hannan, Assistant Professor of Radiation Oncology and lead author for the study. “What we now have is a more potent and effective form of completely noninvasive treatment for prostate cancer, conveniently completed in five treatments.”
Conventional treatment options for early stage prostate cancer include:
- Prostatectomy, the surgical removal of the prostate gland, which can be done with minimally invasive techniques and robotic assistance;
- Brachytherapy, in which doctors implant numerous small radioactive seeds about the size of a grain of rice into the prostate gland using multiple large needles inserted through the skin in the operating room. Once implanted, the seeds release their radioactivity directly into the prostate gland; and
- External beam radiation, which involves 42 to 45 treatments administered over two or more months, five days a week.
“The current form of radiation is 44 treatments given over nine weeks. In contrast, the SBRT therapy we used allows the delivery of highly focused radiation in only five treatments, allowing patients to return to their normal lives more quickly,” said senior author Dr. Robert Timmerman, Director of the Annette Simmons Stereotactic Treatment Center at UT Southwestern, and Professor and Vice Chairman of the Department of Radiation Oncology. “SBRT is both more convenient and has increased potency.”
UT Southwestern served as the lead site for the multi-institutional clinical trial, which involved first-time prostate cancer patients diagnosed with stage I or stage II (low and intermediate risk) prostate cancer. A total of 91 patients were treated prospectively and followed for five years, with only one patient experiencing a recurrence of his cancer. The findings are published in the European Journal of Cancer.
Terry Martin of McKinney, Texas, – about an hour outside Dallas – said the fewer number of treatments was a compelling advantage when he was evaluating treatment options.
“I live 45 minutes away from UT Southwestern. The difference between being treated five times versus 44 times is enormous,” said Mr. Martin, a retired airline pilot. “I felt that I was back to normal just 10 days after finishing treatment.”
In addition to shorter treatment times, researchers found that side effects were not necessarily different compared to other forms of prostate cancer treatment. In the short term, the side effects of SBRT can include urinary issues (urgency, frequency and burning) and rectal irritation, which are often temporary and reverse within four weeks of treatment. Researchers found a small risk of longer-term urinary and rectal complications, which is also comparable to conventional treatments. Decrease in erectile function was seen in 25 percent of patients, fewer than with conventional radiation or surgery, said Dr. Hannan.
The Latest on: Stereotactic Body Radiation Therapy
via Google News
The Latest on: Stereotactic Body Radiation Therapy
MRI-Guided Radiation Therapy System Market Forecast by End-Use Industry 2018-2026
on April 19, 2019 at 7:30 pm
One of the emerging applications of MRI-guided radiation therapy is stereotactic body radiation therapy that offers more precise targeted treatment at higher dosages and in fewer fractions. The ... […]
Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma
on April 3, 2019 at 5:00 pm
- Total bilirubin level ≤ 1.5 × the upper limit of normal (ULN) range - AST and ALT levels ≤ 2.5 × ULN or AST and ALT levels ≤ 5 x ULN (for subjects with documented metastatic disease to the liver). - ... […]
Stereotactic body radiation therapy for pulmonary large cell neuroendocrine carcinoma: a case report
on February 17, 2019 at 1:58 pm
Department of Radiation Oncology, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Cheonan, Republic of Korea Abstract: The incidence of large cell neuroendocrine ... […]
W.P. Holman Clinic commences stereotactic body radiation therapy service
on February 16, 2019 at 10:30 pm
The delivery of state-of-the-art cancer treatment for patients in the state's North was at the core of Dr William Prout Holman's vision when he came to Tasmania in 1925. Now, almost a century later, a ... […]
Stereotactic body radiotherapy effective in treating men with low- or intermediate-risk prostate cancer
on February 10, 2019 at 11:45 pm
This type of radiation, known as stereotactic body radiotherapy, is a form of external beam radiation therapy and reduces the duration of treatment from 45 days to four to five days. The approach has ... […]
Central-Airway Necrosis after Stereotactic Body-Radiation Therapy
on December 19, 2018 at 4:00 pm
Stereotactic body-radiation therapy is a novel technique that aims to deliver higher doses of radiation to cancers in a more focused way. However, adjacent tissues also get higher doses and fatal ... […]
Stereotactic Body Radiation Therapy (SBRT) to the Chest
on December 11, 2018 at 4:00 pm
This information will help you prepare for stereotactic body radiation therapy (SBRT) at Memorial Sloan Kettering (MSK). It will help you know what to expect before, during, and after your treatment. ... […]
Long-Term Benefit for Stereotactic Radiation in Prostate Cancer
on October 30, 2018 at 3:30 am
(HealthDay News) -- For men with low- and intermediate-risk prostate cancer (PCa), stereotactic body radiation therapy (SBRT) seems safe and effective in the long term, according to a study presented ... […]
Stereotactic Body Radiation Therapy Found Safe for Medically Inoperable Early stage Lung Cancer Patients
on July 7, 2018 at 3:10 pm
Early data published from a clinical trial show that Stereotactic Body Radiation Therapy (SBRT) can be used as a safe alternative for surgery in patients with early stage lung cancer. JAMA Oncology ... […]
Stereotactic body radiation therapy (SBRT) in the management of non-small-cell lung cancer: Clinical impact and patient perspectives
on March 15, 2018 at 6:40 pm
1 Department of Oncology, McMaster University, Hamilton, ON, Canada; 2 Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada Abstract: Stereotactic body radiation therapy (SBRT) ... […]
via Bing News